Imprint Wealth’s ResMed RMD Stock Holding History

Imprint Wealth’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.16K	Hold	47	–	–	0.04%	135
2026 Q1	$10.6K	Hold	47	–	–	0.05%	118
2025 Q4	$11.3K	Sell	47 -47	-50%	-$12K	0.05%	138
2025 Q3	$25.7K	Buy	+94	New	+$25.7K	0.08%	107

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Imprint Wealth's RMD Position: Q2 2026 in Review

Imprint Wealth held its ResMed (RMD) position steady in Q2 2026 at 47 shares worth $9.16K. The position accounts for 0.04% of the portfolio, ranked #135.

Imprint Wealth first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $25.7K in Q3 2025. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Imprint Wealth held 47 shares of ResMed worth $9.16K as of Q2 2026.
Imprint Wealth left its ResMed share count unchanged in Q2 2026.
ResMed made up 0.04% of Imprint Wealth's portfolio in Q2 2026, its #135 holding.
Imprint Wealth first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
Imprint Wealth's ResMed position peaked at $25.7K in Q3 2025.
888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Imprint Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.